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Abstract
Objective Attention-deficit hyperactivity disorder
(ADHD) medications are subject to abuse, misuse, and
diversion. Obtaining ADHD prescriptions from multiple
prescribers or filled across multiple pharmacies, known as
‘doctor shopping’, may reflect such unsanctioned use. We
sought to create a definition of shopping behavior that
differentiated ADHD medications from medications with
low risk of diversion, i.e. asthma medications, and describe
the incidence, frequency, and demography of shopping
behavior.
Methods This was a retrospective cohort study in a
pharmacy database—LRx—covering 65 % of US retail
pharmacies. Subjects had ADHD or asthma medication
dispensed between February 2011 and January 2012. We
followed subjects for 18 months to assess the number with
overlapping dispensings from different prescribers, and the
number of prescribers and pharmacies involved in those
dispensings.
Results We included 4,402,464 subjects who were dis-
pensed ADHD medications, and 6,128,025 subjects who
were dispensed asthma medications. Overlapping pre-
scriptions from two or more prescribers dispensed by three
or more pharmacies was four times more frequent in the
ADHD cohort than in the asthma cohort. Using this defi-
nition, ADHD medication shopping behavior was more
common among experienced users than naı¨ve users, and
was most common in subjects aged 10–39 years. Among
subjects who shopped, 57.4 % shopped only once
(accounting for 22.4 % of episodes), and 9.2 % shopped
six or more times (accounting for 42.0 % of episodes).
Shoppers more often received stimulant ADHD drugs than
non-stimulants.
Conclusions Overlapping prescriptions by different pre-
scribers and filled at three or more pharmacies defines
ADHD medication shopping. Shopping behavior is most
common in adolescents and younger adults. A small pro-
portion of shoppers is responsible for a large number of
shopping episodes.
Key Points
Attention-deficit hyperactivity disorder (ADHD)
medications may be subject to abuse, misuse, and
diversion.
We found that overlapping prescriptions from two or
more prescribers dispensed by three or more
pharmacies defines ADHD medication shopping.
1 Introduction
Medications for the treatment of attention-deficit hyper-
activity disorder (ADHD) are subject to misuse, abuse, and
diversion [1–3]. The non-medical use of ADHD medica-
tions in high-school-age children in the US is estimated at
around 9 %, and in college-age individuals goes from 5 to
35 % [1]. The increase in recent years in the number of
emergency visits involving ADHD medications for non-
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medical use (use not prescribed for the respondent by a
physician or use only for the experience or feeling caused
[4]) [5] reflects these problems. Obtaining ADHD pre-
scriptions from multiple prescribers and/or filling pre-
scriptions across multiple pharmacies, often called doctor
or pharmacy shopping, may reflect such unsanctioned use
[1, 6].
Doctor-shopping behavior is increasingly recognized for
opioids [7–10], but less is known about doctor-shopping
behavior for ADHD medications. On the basis of data from
California’s Prescription Monitoring Programs, 1.4 % of
subjects dispensed ADHD medication had multiple pro-
viders in 2007 [11]. However, it is unclear how the
behavior should be defined, how many individuals engage
in the behavior (incidence), how often it occurs in a given
subject or across subjects (frequency), the impact of age
and sex on such behavior, or whether a small proportion of
subjects are responsible for a large proportion of shopping
episodes (concentration).
Developing a definition of shopping behavior for ADHD
medications will help identify subjects who may be at
higher risk of misusing/abusing or diverting. We sought to
create an operational definition of shopping behavior that
differentiated ADHD medications from medications with
low risk of abuse or diversion, such as asthma medications.
Such a definition will therefore decrease the risk of inap-
propriately identifying individuals with legitimate use of
ADHD medications as being at increased risk of misusing/
abusing or diverting those medicines. Such misclassifi-
cation may adversely affect the individual who is mis-
classified (e.g. social stigma) and, secondly, it is potentially
deleterious to research studies that assess shopping
behavior and abuse because random misclassification
would bias the studies toward the null and thus obscure the
signals of interest. Once we defined shopping behavior, we
also sought to describe its incidence and frequency, the
impact of age and sex on shopping behavior, and the type
of ADHD medication involved in the shopping episodes.
2 Method
2.1 Data Collection
We conducted a population-based retrospective cohort
study using the LRx database, a longitudinal pharmacy
database that covers 65 % of all retail dispensing in the US
and includes all types of pharmacies—chains, food stores,
mass merchandisers, and independent stores. From each of
the pharmacies in the panel, the database captures all
prescriptions that were dispensed, regardless of payment
type. In particular, it includes prescriptions filled for
patients with any insurance type (commercial, Medicare,
Medicaid) and prescriptions paid for entirely in cash.
Dispensing records are collected directly from pharmacies,
which provide encrypted patient identifiers compliant with
Health Insurance Portability and Accountability Act (HI-
PAA) privacy regulations. The LRx database includes data
on the subject (de-identified), the pharmacy, and the
prescriber.
To uniquely identify a subject who filled prescriptions at
multiple pharmacies, a probabilistic multi-level match was
performed using a proprietary algorithm based on encryp-
ted non-identifiable data elements including sex, date of
birth, last name, first name, address, city, state, zip code,
and payer identification.
2.2 Inclusion Criteria
We included all subjects dispensed an ADHD or asthma
medication between 1 February 2011 and 31 January 2012
who had data available for at least 4 months prior to the
first dispensing (index date), and whose pharmacies con-
sistently supplied data to the LRx database during the
entire study period. Each subject was followed for
18 months from his/her index date.
A subject who was dispensed ADHD and asthma med-
ications could be a member of both cohorts.
2.3 Prescription/Dispensing Data
We included all ADHD medications whose ingredients
were approved by the US FDA for the treatment of ADHD.
These were the stimulants amphetamine, dexmethylpheni-
date, dextroamphetamine, lisdexamfetamine, methamphet-
amine, and methylphenidate, and the non-stimulants
atomoxetine, clonidine, and guanfacine.
The asthma medications included were inhaled bron-
chodilators, inhaled steroids, inhaled steroid/long-acting b
agonist combinations, and oral leukotriene inhibitors.
Asthma medications were used as a comparator because
they are frequently used by a population with roughly
similar demographic characteristics as the population using
ADHD medications [12], including a large representation
of children and young adults, and are not believed to be
widely abused or diverted [13].
Subjects who were not dispensed any ADHD medication
during the 4 months before their index date were consid-
ered ‘naive’. The 4-month period, rather than a shorter
period, was adopted to decrease the risk of misclassifying
as naı¨ve a subject who was receiving an ADHD medication
during the school year but took a planned break in its use
during 3 or 4 months of vacation (i.e. took a ‘drug
holiday’).
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2.4 Outcome
We assessed the number of subjects with overlapping
dispensings of medications prescribed by different pre-
scribers, and the number of prescribers and number of
pharmacies involved in those dispensings, during the
18 months of follow-up. For subjects with more than one
event of multiple overlapping filled prescriptions, we
selected the one event with the maximum number of
overlapping prescriptions. Note that a prescriber can write
more than one prescription for a given individual, therefore
the total number of pharmacies making dispensings for that
individual may exceed the number of prescribers.
An overlap occurred when two or more dispensings of
medications prescribed by different prescribers were active
on the same day (i.e. a medication was dispensed during
the days’ supply of another dispensed medication). The
overlapping dispensings could be for the same or different
ADHD or asthma medications.
To set a definition of shopping behavior that differen-
tiated ADHD medications from asthma medications, we
qualitatively compared the frequency distribution of sub-
jects across the number of prescribers and pharmacies
between the two cohorts—the larger the ratio in the pro-
portion of subjects, the larger the difference in behavior
between the two cohorts. The best cut-off of number of
pharmacies and number of prescribers also had to have a
sufficient proportion of subjects to provide a useful marker
of unsanctioned use.
Once the definition was selected, we identified subjects
who met the definition, i.e. subjects with at least one event
of overlapping prescriptions written by two or more pre-
scribers and filled at three or more pharmacies. The index
or qualifying event did not necessarily occur during the
episode with the highest number of overlapping prescrip-
tions. We then assessed how soon the shopping episode
was observed during follow-up of a given subject (i.e.
median time from index date to first shopping episode), the
total number of events across all subjects according to age
category, sex, and prior exposure (naı¨ve or experienced),
and the concentration of shopping (extent to which a rel-
atively small proportion of shoppers accounted for a rela-
tively large proportion of shopping episodes). Each time
there was a new dispensing, the definition of shopping
behavior was applied and, if the criteria were met, a new
shopping episode was counted.
To make sure that the subjects dispensed prescribed
asthma medication had a similar age distribution to the
subjects dispensed ADHD medications, the asthma sub-
jects were frequency-matched to the ADHD subjects by
single year of birth.
This study used completely anonymized data and did not
involve patient contact. The New England Institutional
Review Board determined that this was not human-subject
research.
3 Results
A total of 4,402,464 subjects dispensed ADHD medica-
tions and 6,128,025 subjects dispensed asthma medications
were included in the analysis. The age distribution
(mean ± SD) of the subjects was similar in the two
cohorts—24.1 ± 16.2 years of age in the ADHD medica-
tion cohort and 24.2 ± 16.8 in the asthma medication
cohort, as would be expected from the age matching. In the
ADHD medication cohort, 43.9 % were female, and in the
asthma medication cohort, 55.6 % were female.
The distribution of pharmacies and prescribers visited
by subjects was markedly different in subjects who
received ADHD drugs compared with those who received
asthma drugs.
Overlapping prescriptions written by two or more pre-
scribers and dispensed at two or more pharmacies were
approximately twofold more frequent in the ADHD med-
ication cohort than in the asthma medication cohort, and
occurred in 198,923 subjects in the ADHD medication
cohort (4.5 %) and in 120,163 subjects in the asthma
medication cohort (2.0 %) [Tables 1 and 2].
Overlapping prescriptions written by two or more pre-
scribers and dispensed at three or more pharmacies were
approximately fourfold more frequent in the ADHD med-
ication cohort than in the asthma medication cohort, and
occurred in 11,861 subjects in the ADHD medication
cohort (0.27 %) and in 4,226 subjects in the asthma med-
ication cohort (0.07 %) [Tables 1 and 2].
Overlapping prescriptions written by two or more pre-
scribers and dispensed at five or more pharmacies were
approximately 28-fold more frequent in the ADHD medi-
cation cohort than in the asthma medication cohort; how-
ever, this occurred in only 143 subjects in the ADHD
medication cohort (0.003 %), and in seven subjects in the
asthma medication cohort (0.0001 %) [Tables 1 and 2].
We therefore adopted overlapping prescriptions written
by two or more prescribers and filled at three or more
pharmacies as the definition of ADHD medication shop-
ping behavior. This definition of shopping behavior clearly
discriminated between subjects dispensed ADHD medica-
tions and subjects dispensed asthma medications, and was
sufficiently common to serve as a marker suggestive of
unsanctioned use.
Using this definition, we found that ADHD medication
shopping behavior was most commonly observed between
10 and 39 years of age. No large differences in frequency
of shopping behavior were observed between men and
women. Shopping behavior was observed in 13,707
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(0.6 %) of 2,360,546 non-naı¨ve subjects, and in 4,423
(0.2 %) of 2,041,918 naı¨ve subjects (Table 3). Note that
this prevalence of shopping behavior is higher than that
observed in Table 1 because of the different ways episodes
were counted, as described in Sect. 2.4.
Among subjects who shopped, the median time from the
first dispensing of ADHD medications to the first shopping
episode was approximately 7 months, and was slightly
shorter in non-naı¨ve subjects than naı¨ve subjects (Table 3).
Approximately 58 % of all subjects dispensed ADHD
medications who exhibited shopping behavior had only one
episode of shopping during the 18 months of follow-up,
and these subjects accounted for 22.4 % of all shopping
episodes. In contrast, the 9.2 % of shoppers who shopped
six times or more accounted for 42.0 % of all the shopping
episodes (Table 4). Relative to non-shoppers and the
overall group of shoppers, these latter subjects were more
likely to be between 30 and 39 years of age and not naı¨ve
to ADHD medications (Table 3).
Dispensing of stimulant ADHD medications was more
common among subjects exhibiting shopping behavior than
among subjects without such behavior; odds ratio 8.3,
95 % confidence interval 6.9–10.2 (Table 5).
4 Discussion
This large population-based cohort study suggests that the
operational definition of ADHD medication shopping
behavior has the greatest discriminative value when sub-
jects have overlapping prescriptions for ADHD medica-
tions written by different prescribers and filled at three or
more pharmacies. Similar behavior is very rare in subjects
prescribed asthma medications.
A study conducted in a French claims database found,
similar to our findings, that a small proportion of subjects
(0.5–1 %) received their medication from a large number
of distinct prescribers and pharmacies, which suggested
abuse [14].
The definition of shopping behavior for ADHD medi-
cations is the same as for opioids [7, 8]. Similarly to opioid
shopping behavior, shopping behavior is observed in less
than 1 % of those dispensed ADHD medications and ten-
ded to occur in young adults; approximately half the sub-
jects who exhibited shopping behavior did so only once,
and a small proportion of subjects accounted for a dis-
proportionately large percentage of shopping episodes. As
for opioids, subjects with prior exposure were more likely
Table 1 Number of subjects exposed to ADHD medications, with their number of prescribers and pharmacies visiteda
Number of pharmacies 1 2 3 4 5 6 7 Total
Number of prescribers
1 3,555,122 (80.8) (0) (0) (0) (0) (0) (0) 3,555,122 (80.8)
2 640,049 (14.5) 182,818 (4.2) 9,056 (0.2) 611 (0) 44 (0) 8 (0) 2 (0) 832,588 (18.9)
3 8,183 (0.2) 4,141 (0.1) 1,616 (0) 278 (0) 48 (0) 4 (0) 1 (0) 14,271 (0.3)
4 184 (0) 100 (0) 88 (0) 57 (0) 20 (0) 3 (0) (0) 452 (0)
5 3 (0) 2 (0) 4 (0) 7 (0) 6 (0) 5 (0) 1 (0) 28 (0)
6 (0) 1 (0) 1 (0) (0) 1 (0) (0) (0) 3 (0)
Total 4,203,541 (95.5) 187,062 (4.2) 10,765 (0.24) 953 (0) 119 (0) 20 (0) 4 (0) 4,402,464 (100)
ADHD attention-deficit hyperactivity disorder
a The figure in parentheses represents the percentage of the total number of subjects (4,402,464)
Table 2 Number of subjects exposed to asthma medications, with their number of prescribers and pharmacies visiteda
Number of pharmacies 1 2 3 4 5 9 Total
Number of prescribers
1 5,320,404 (86.8) (0) (0) (0) (0) (0) 5,320,404 (86.8)
2 650,913 (10.6) 106,486 (1.7) 2,748 (0) 68 (0) 2 (0) 1(0) 760,218 (12.4)
3 34,526 (0.6) 8,731 (0.1) 1,169 (0) 44 (0) 2 (0) (0) 44,472 (0.7)
4 1,931 (0) 665 (0) 147 (0) 18 (0) 2 (0) (0) 2,763 (0.1)
5 85 (0) 52 (0) 17 (0) 6 (0) (0) (0) 160 (0)
6 3 (0) 3 (0) (0) 1 (0) (0) (0) 7 (0)
7 (0) (0) 1 (0) (0) (0) (0) 1 (0)
Total 6,007,862 (98) 115,937 (1.9) 4,082 (0.07) 137 (0) 6 (0) 1(0) 6,128,025 (100)
a The figure in parentheses represents the percentage of the total number of subjects (6,128,025)
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to become shoppers. Also in parallel with opioid shoppers,
who tended to receive strong opioids, ADHD medication
shoppers were more likely to receive ADHD medications
that are stimulants.
The fact that the criteria that serve to identify subjects
who engage in ADHD medication shopping behavior and
opioid shopping behavior are similar seems to suggest that
overlapping prescriptions written by different prescribers
and filled at three or more pharmacies can be used as an
operational definition to assess shopping behavior for
medications that are prone to abuse and diversion in gen-
eral. It is worth noting that subjects abusing a specific drug
are likely to abuse other drugs or have a higher risk of
developing abuse when exposed to other medications with
abuse potential [15–18].
In contrast to opioids for which 0.5 % of shoppers were
aged 18 years or younger [8], we found that at least 13 %
of shoppers were very young (less than 10 years of age);
this finding likely represents diversion by their parents or
caregivers [19]. We also found that a small number of
subjects were responsible for a disproportionately large
number of shopping episodes, which likely also represents
diversion of ADHD medications. A survey of undergrad-
uate students found that their leading source of ADHD
medications for non-medical use was friends and peers
[20].
Table 3 Incidence of shopping behavior, time to first shopping episode, number of subjects with six or more shopping episodes, by age, sex,
and prior use of ADHD medications
Group Number of subjects exposed to
ADHD medications (col. %)
Number (col. %) of subjects
with shopping behavior
Number of days to first
shopping episode (median)
Number (col. %) of subjects with
six or more shopping episodes
Total 4,402,464 18,130 (0.4) 225 1,666 (9.2)
Age, years
\10 640,430 (14.5) 2,322 (12.8) 287.5 70 (4.2)
10–19 1,714,153 (38.9) 3,794 (20.9) 246 193 (11.6)
20–29 743,932 (16.9) 4,517 (24.9) 227 418 (25.1)
30–39 457,853 (10.4) 3,789 (20.9) 190 506 (30.4)
40–49 392,840 (8.9) 2,084 (11.5) 202.5 253 (15.2)
50–59 296,421 (6.7) 1,275 (6) 195 175 (10.5)
60–69 116,655 (2.6) 302 (1.7) 163 45 (2.7)
C70 40,180 (0.9) 47 (0.3) 207 6 (0.4)
Sex
Female 1,934,829 (43.9) 8,807 (48.6) 214 910 (54.6)
Male 2,467,635 (56.0) 9,323 (51.4) 234 756 (45.4)
Prior use of ADHD medications
Naı¨ve 2,041,918 (46.4) 4,423 (24.4) 237 222 (13.3)
Non-naı¨ve 2,360,546 (53.6) 13,707 (75.6) 221 1,444 (86.7)
Prior use of ADHD medications refers to the presence or absence of dispensing 4 months prior to the initial prescription in the study period
ADHD attention-deficit hyperactivity disorder, Col. Column
Table 4 Frequency of
shopping episodes for subjects
with shopping behavior
Number of shopping
episodes during the follow-up period




1 10,413 (57.4) 10,413 (22.4)
2 3,345 (18.5) 6,690 (14.4)
3 1,443 (8.0) 4,329 (9.3)
4 795 (4.4) 3,180 (6.9)
5 468 (2.6) 2,340 (5.0)
6–9 915 (5.1) 6,637 (14.3)
10–20 585 (3.2) 7,834 (16.9)
21–83 166 (0.9) 4,992 (10.8)
Total 18,130 46,415
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The low frequency of shopping behavior observed in
this study is likely to be an underestimate of the true
incidence. The LRx database does not have 100 % cover-
age of all pharmacy transactions in the US, and online
transactions are not covered. Of note, the matching algo-
rithm used to uniquely identify subjects could fail to
identify two subjects as the same individual if a minimum
number of required encrypted attributes did not match, and
thus would fail to discern a subject who presented false
identification. However, no other data source will permit an
assessment across the whole of the US or will capture cash
prescriptions, which are very relevant when evaluating the
risk of diversion [8].
We aimed for a definition that would avoid false posi-
tives (subjects who, for many reasons, could have different
prescribers and pharmacies but were not shopping). A
definition that limits misclassification of subjects, espe-
cially by reducing the number of false positive subjects, is
crucial for research and health policy. To obtain such
definition, we compared subjects dispensed asthma medi-
cations, which are less likely to be abused, with subjects
dispensed ADHD medications with a higher intrinsic risk
of abuse. Asthma and ADHD medications differ with
respect to scheduling, and may differ in patterns of pre-
scription (e.g. number of prescribers involved in care).
These distinctions may have differentially affected our
estimates of the numbers of prescribers and pharmacies
visited by subjects in the asthma medication cohort and
thus confounded the observed differences in shopping
behavior between the two groups. In addition, this study
did not address possible differences in socioeconomic
status between the asthma and ADHD medication cohorts.
For example, if the prevalence of asthma and lack of
continuity in care are associated with low socioeconomic
status, then this could lead to a higher risk of a subject with
asthma being classified as a shopper, with socioeconomic
status being a mediating factor.
We found a small difference in the median time to
first shopping episode between naı¨ve and non-naı¨ve
ADHD medication subjects. The small size of this dif-
ference may reflect misclassification error, with subjects
who were non-naı¨ve being classified as naı¨ve because
the look-back period that we implemented was limited to
4 months, while the recommended medication-free per-
iod (‘drug holiday’) for ADHD medications may have
extended beyond 4 months. We also observed dispen-
sings of ADHD medications to subjects aged 70 years or
older. These dispensings could be for the treatment of
conditions different from ADHD. However, we report
the incidence of shopping behavior stratified by age
category.
This study did not assess the intent of subjects who
engaged in shopping behavior or the association with the
comorbid diagnosis of substance abuse or dependence. It
can be argued that counting the number of distinct
pharmacies and prescribers is more objective and accu-
rate than measuring a construct that is subjective and
difficult to measure, such as abuse or dependence. Our
intent was to find a combination of pharmacies and
prescribers that differentiated between subjects pre-
scribed ADHD medications who were more likely to
engage in non-medical use, and subjects prescribed
medications that are not prone to abuse or dependence,
such as asthma medications. We found such a definition.
Furthermore, the behavior was more commonly observed
in young subjects, which strengthens the validity of the
findings. In addition, the definition for ADHD medica-
tion shopping behavior was found to be the same as the
one used to define opioid shopping behavior, and that
definition has been explicitly linked to opioid abuse [21].
Nonetheless, understanding why subjects need to visit
multiple pharmacies and prescribers, and determining
whether or not they are misusing, abusing, or diverting
the ADHD medications, will increase the acceptance of
the definition of shopping behavior as it relates to
ADHD medications, and will help health care providers
or insurers implement monitoring to decrease the risk of
abuse or diversion.
Table 5 Type of ADHD dispensed to subjects with and without shopping behaviora
Number (%) of subjects
without shopping behavior
Number (%) of subjects
with shopping behavior
Odds ratio (95% CI) for shopping
behavior vs. being dispensed any
stimulant ADHD medication
Stimulants 4,179,353 (95.3) 18,024 (99.4) 8.3 (6.9–10.2)
No stimulants 204,981 (4.7) 106 (0.6)
Total number (%) of subjects 4,384,334 (100) 18,130 (100)
ADHD attention-deficit hyperactivity disorder, CI confidence interval
a For subjects exhibiting shopping behavior, we looked for stimulants during any shopping episode; for non-shoppers we looked for stimulants
during any dispensing
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5 Conclusions
ADHD medication shopping behavior can be defined as
subjects with overlapping prescriptions written by two or
more prescribers and filled at three or more pharmacies.
Shopping behavior is more commonly observed in younger
ages, and a small number of subjects is responsible for a
disproportionately large number of shopping episodes.
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